Dulsevia 60 mg tvrde želučanootporne kapsule
Name | Dulsevia 60 mg tvrde želučanootporne kapsule |
---|---|
Marketing Authorisation Number | HR-H-235080527 |
Active Substance | duloksetinklorid |
Composition | svaka tvrda želučanootporna kapsula sadrži 60 mg duloksetina (u obliku duloksetinklorida) |
Pharmaceutical Form | želučanootporna kapsula, tvrda |
Packaging [MA Number for Packaging] | 7 kapsula u blisteru, u kutiji [HR-H-235080527-01] 10 kapsula u blisteru, u kutiji [HR-H-235080527-02] 14 kapsula u blisteru, u kutiji [HR-H-235080527-03] 28 kapsula u blisteru, u kutiji [HR-H-235080527-04] 30 kapsula u blisteru, u kutiji [HR-H-235080527-05] 56 kapsula u blisteru, u kutiji [HR-H-235080527-06] 60 kapsula u blisteru, u kutiji [HR-H-235080527-07] 90 kapsula u blisteru, u kutiji [HR-H-235080527-08] 100 kapsula u blisteru, u kutiji [HR-H-235080527-09] |
Manufacturer | TAD Pharma Gmbh, Cuxhaven, Njemačka Krka d.d., Novo mesto, Novo Mesto, Slovenija |
Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
Marketing Authorisation Date | 28.01.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/19-02/125 |
Registration Number | 381-12-01/38-20-03 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N06AX21 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |